Verstappen M, Matthijssen XME, van der Helm-van Mil AHM. Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies-results from a 25 year longitudinal inception cohort. Rheumatology (Oxford) 2022;61(8):3212-22. https://www.ncbi.nlm.nih.gov/pubmed/34850952
Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF. Drug therapy in undifferentiated arthritis: a systematic literature review. Ann Rheum Dis 2013;72(9):1436-44. https://www.ncbi.nlm.nih.gov/pubmed/23744979